NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cyclana Bio

Cyclana Bio

Private
CambridgeHealthcare & Life Scienceshttps://www.cyclanabio.com/

Last Round

Pre Seed

Oct 20, 2025

Total Funding Raised

$6.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cyclana Bio is a biotechnology company that develops a therapeutic discovery platform using whole-tissue models and AI-driven data integration to identify treatments for endometriosis and other chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

endometriosis treatmentdrug discoverywomen's healthfemtechtissue modelsin vitro researchextracellular matrixcomputational biologybiomarker analysisdrug target identificationprecision medicinehydrogel screeningbiotech startuptherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cyclana Bio Comparables

Compare Cyclana Bio with similar companies based on industry and business-model similarity.

Cyclana Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Metri Bio
90%
GynQura Therapeutics
87%
EndoGene.Bio
79%

Cyclana Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 20, 2025

Key People

Founding team and executive leadership

Léa Wenger

Chief Executive Officer And Founder

Founding Team

Jonathan Griffiths

Chief Technology Officer

Executive Team

Cyclana Bio Investors

Notable investors and investment history

Cyclana Bio investors
InvestorRounds
NFXPre Seed
Cocoa VenturesPre Seed
Eka VenturesPre Seed
Wilbe CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Grew 43% QoQ, from 7 to 10 employees.

  • Oct 20, 2025

    $7M round led by Eka Ventures and NFX.

Cyclana Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cyclana Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cyclana Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range12
Year Founded2024
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.